Sector consensus Charles River Laboratories International, Inc.

Stocks

Real-time Estimate Cboe BZX Other stock markets 07:15:34 02/07/2026 pm IST			5-day change	1st Jan Change
231.14 ^USD	+0.89%		+13.35%	+14.84%

02/07	Charles River Laboratories International Insider Sold Shares Worth $16,875,000, According to a Recent SEC Filing	MT
01/07	Argus Raises Price Target on Charles River Laboratories International to $250 From $200, Maintains Buy Rating	MT

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Average Target P.	Objective/dr gap	Nbr of analysts
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	215.33	-6%	15
LONZA GROUP AG	665.48	+18.29%	23
REVOLUTION MEDICINES, INC.	193.04	+2.95%	22
IQVIA HOLDINGS INC.	226.47	+11.45%	19
BEONE MEDICINES AG	412.38	+41.84%	27
CELLTRION, INC.	2,54,025.79	+45.57%	24
ASCENDIS PHARMA A/S	255.9	+9.14%	18
MEDPACE HOLDINGS, INC.	443.5	-18.41%	12
EUROFINS SCIENTIFIC SE	71.03	+3.75%	14
ICON PUBLIC LIMITED COMPANY	178.31	+1.86%	16
IONIS PHARMACEUTICALS, INC.	105.91	+33.75%	23
BIO-TECHNE CORPORATION	69.08	-2.7%	12
ABIVAX	120.06	+2.18%	6
TEMPUS AI, INC.	66.06	+7.24%	16
APOGEE THERAPEUTICS, INC.	130.53	-1.69%	12
KYMERA THERAPEUTICS, INC.	123.76	+8.37%	21
PRAXIS PRECISION MEDICINES, INC.	619.78	+93.92%	18
ALKERMES PLC	49.44	-4.41%	16
QIAGEN N.V.	43.96	+12.35%	14
IMMUNOVANT, INC.	46	+20.61%	17
Average	12,903.09	+14.00%	17
Weighted average by Cap.	18,296.19	+15.47%	19